- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pediatric medulloblastoma express immune checkpoint B7-H3 ; day:5 ; month:1 ; year:2022 ; pages:1-5
Clinical and translational oncology ; (5.1.2022), 1-5
- Creator
-
Li, S.
Poolen, G. C.
Vliet, L. C. van
Schipper, J. G.
Broekhuizen, R.
Monnikhof, M.
Hecke, W. Van
Vermeulen, J. F.
Bovenschen, N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-021-02762-y
- URN
-
urn:nbn:de:101:1-2022042301223506152035
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, S.
- Poolen, G. C.
- Vliet, L. C. van
- Schipper, J. G.
- Broekhuizen, R.
- Monnikhof, M.
- Hecke, W. Van
- Vermeulen, J. F.
- Bovenschen, N.
- SpringerLink (Online service)
Other Objects (12)
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Identification of the receptor B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
B7-H3 is widely expressed in soft tissue sarcomas
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Identification of the receptor B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
B7-H3 is widely expressed in soft tissue sarcomas
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Identification of the receptor B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
B7-H3 is widely expressed in soft tissue sarcomas
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer